ResMed10-Q: Platform strategyApr 30, 2026

ResMed commits to $984M in purchase obligations for the upcoming year

What happened

The company has disclosed nearly $1 billion in contractual purchase obligations due within the next 12 months, signaling a massive, planned spend on its supply chain and manufacturing operations.

Source

SEC EDGARApr 30, 2026

Quarterly report (Form 10-Q)

ResMed 10-Q

Filing excerpt

Purchase obligations$1,033,281 $984,028 $39,089 $6,265 $2,334 $619 $946

sec.gov/Archives/edgar/data/943819/000094381926000025/rmd-20260331.htmRead the full source

Other signals in this filing (6)

Supply chain disruptionResMed using $3.4B currency swap program to manage risk from international manufacturing.Supply chain disruptionApr 30, 2026
Logistics challengeResMed reports over $1B in purchase obligations, with $984M due within a year.Logistics challengeApr 30, 2026
Platform strategyResMed triples currency hedging program to $3.4B to manage international riskPlatform strategyApr 30, 2026
Margin pressureResMed warns that inflation may adversely affect gross margin and operating results.Margin pressureApr 30, 2026
Pricing pressureResMed flags potential inability to pass on rising costs through price increases.Pricing pressureApr 30, 2026
Inflation impactResMed cites inflation impacting product costs, freight, and overhead.Inflation impactApr 30, 2026

Extracted by Autobound

From the Signal API record

Signal: 10-Q: Platform strategy

What this signalsFilings often name leadership changes, deals and spending plans.

Fiscal year end: 03/31
Filed: Apr 30, 2026

More 10-Q signals at other companies

SEC 10-QMillerKnoll, Inc.Jeffrey M. Stutz appointed Interim Chief Executive Officer.SEC 10-QSep 28, 2026
SEC 10-QCID HoldCo, Inc.Disclosed material weaknesses in financial reporting due to insufficient accounting staff and controls.SEC 10-QSep 25, 2026
SEC 10-QScholastic CorporationCore school channels decline with fewer book fairs and lower club participation.SEC 10-QSep 25, 2026

The full record

From the Signal API record

Numbers

Dollar figure: $984M (Purchase obligations due by March 31, 2027)

Details

CIK: 943819
Accession number: 0000943819-26-000025
Timeframe: Next year
Filing year: 2026
Fiscal year: 0
Why it matters: Platform tools needed
Signal category: Strategic

Extraction

Confidence: Medium
Relevance: 90%
Sentiment: Positive
Detected: May 5, 2026
signal_type: sec-10q
signal_subtype: platformStrategy

Use this data

Get every 10-Q signal for ResMed and the companies you sell to, in the tools you already use.

Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at ResMed this week?”
MCP setup guide
Send it to your own tools
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Signal API
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

linkedin_urlValue in the API
industriesValue in the API
employee_count_lowValue in the API
employee_count_highValue in the API
revenueValue in the API
descriptionValue in the API

Signal

signal_nameValue in the API
associationValue in the API

Start Free1,000 free creditsUse it in Claude via MCP

Show the full JSONThe record on this page and the API request

GET /v1/signals/7149e68a-a114-4782-8cb6-c7bff689e921 returns this record as JSON. POST /v1/companies/enrich returns every signal for resmed.com.

{
  "signal_id": "7149e68a-a114-4782-8cb6-c7bff689e921",
  "signal_type": "sec-10q",
  "signal_subtype": "platformStrategy",
  "detected_at": "2026-05-05T08:48:21.198+00:00",
  "company": {
    "name": "ResMed",
    "domain": "resmed.com"
  },
  "data": {
    "detail": "The company has disclosed nearly $1 billion in contractual purchase obligations due within the next 12 months, signaling a massive, planned spend on its supply chain and manufacturing operations. This level of procurement activity may strain existing systems, creating opportunities for supply chain management, procurement, and ERP solutions to improve efficiency and visibility.",
    "metrics": {
      "timeframe": "next_year",
      "dollar_context": "Purchase obligations due by March 31, 2027",
      "dollar_millions": 984.028
    },
    "summary": "ResMed commits to $984M in purchase obligations for the upcoming year",
    "excerpts": "Purchase obligations$1,033,281 $984,028 $39,089 $6,265 $2,334 $619 $946",
    "relevance": 0.9,
    "sentiment": "positive",
    "confidence": "medium",
    "source_url": "https://www.sec.gov/Archives/edgar/data/943819/000094381926000025/rmd-20260331.htm",
    "filing_date": "2026-04-30",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "03/31",
    "sales_relevance": "Platform tools needed",
    "signal_category": "strategic"
  }
}

curl https://signals.autobound.ai/v1/signals/7149e68a-a114-4782-8cb6-c7bff689e921 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"resmed.com","limit":20}'

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.